Pittsburgh Paints Co. Introduces PITTSBURGH PAINTS Protective Coatings
Pittsburgh Paints Co. has launched its new PITTSBURGH PAINTS™ Protective Coatings brand, replacing PPG HIGH PERFORMANCE COATINGS™. The new brand introduces BUILDING RENEWAL® NEVERFADE® Exterior Coatings with KYNAR AQUATEC® PVDF resin for architectural use, designed to extend the life of building materials with a 15-year warranty. Pittsburgh Paints Co. will also be the exclusive distributor for PPG’s Protective & Marine Coatings across the U.S. and Canada.
SJM Maintained by UBS -- Price Target Lowered to $121
UBS analyst Peter Grom has maintained a "Buy" rating for JM Smucker (SJM) but lowered its price target from $132 to $121, reflecting a cautious outlook despite seeing continued value. GuruFocus indicates SJM is 16.4% undervalued at its current price of $100 compared to its GF Value™ of $119.61. Insider activity shows more buys than sells, suggesting optimism, while the company's GF Score™ of 67/100 points to strong valuation but challenges in growth.
Pdf Solutions stock hits all-time high at 56.47 USD
PDF Solutions Inc. (PDFS) stock reached an all-time high of $56.47, trading at $56.27 with a market capitalization of $2.33 billion. The company has seen a 188% appreciation in stock value over the last year and reported strong first-quarter 2026 earnings, exceeding analyst expectations for EPS and revenue. Analyst firms like Rosenblatt and DA Davidson have maintained or raised their price targets, indicating strong investor confidence despite a recent public offering.
Wells Fargo CEO Finds it 'Surprising' People are Debating AI
Wells Fargo CEO Charlie Scharf expressed surprise at the polarized debate surrounding AI and employment, stating that the technology simultaneously drives productivity and displaces jobs. He highlighted that Wells Fargo is expanding AI implementation, particularly through a partnership with Google Cloud, to improve efficiency and reduce manual processes. Other financial institutions like JPMorgan Chase and Block are also accelerating AI adoption, with Block notably reducing its workforce due to AI-driven productivity gains.
Eversource project ‘epitomizes’ flawed transmission reviews: New England states
The New England States Committee on Electricity (NESCOE) informed FERC that Eversource Energy's X-178 transmission project in New Hampshire highlights the urgent necessity for reforming the region's "asset condition" review process. NESCOE states that New England lacks sufficient regulatory oversight for asset condition projects, which involve replacing aging transmission infrastructure. While Eversource maintains it followed all rules and that its project was extensively reviewed, ratepayer advocates argue the company misclassified the project to avoid scrutiny, prompting calls for an audit and stricter review processes.
Photronics, Inc. (PLAB) Scrutinized After $1.1 Billion Market Cap Wipeout Amid Operational Reality Surprise – HBSS
Hagens Berman Sobol Shapiro LLP has initiated an investigation into Photronics, Inc. (NASDAQ: PLAB) after the company's shares plunged 36% on May 28, 2026, wiping out $1.1 billion in market capitalization. This follows Q2 2026 results that contradicted earlier statements about its operations, particularly concerning a tax valuation allowance reversal in December 2025 which had significantly boosted non-GAAP EPS. The firm is investigating whether Photronics misled investors regarding its accounting practices.
Eli Lilly issues data sharing ultimatum to 340B hospitals
Eli Lilly has issued an ultimatum to hospitals and medical groups participating in the 340B drug discount program, requiring them to comply with data sharing requirements by Monday or lose access to discounts on Lilly medications. The company asserts this is necessary to prevent double-dipping of discounts with other programs like Medicaid, while hospitals argue the demand is illegal and an attempt to limit 340B payments. This move follows Lilly's January announcement of the data requirement, which it had not yet enforced, and is part of a broader trend among major drugmakers seeking to reform and audit the 340B program.
Cessna Citation CJ4 Gen3 Approaches FAA Certification as 500th CJ4 Rolls Out
Textron Aviation has rolled out its 500th Citation CJ4 series aircraft, which is a CJ4 Gen2 model, marking a significant milestone. Concurrently, the company is anticipating FAA certification for the upgraded CJ4 Gen3 by the end of 2026. This indicates ongoing development and production momentum for the Citation CJ4 series.
Philips (PHG) Gains Regulatory Approval for Elevate Plus Ultraso
Koninklijke Philips NV (PHG) has received U.S. regulatory approval for its Elevate Plus system, which enhances its EPIQ Elite and Affiniti ultrasound platforms with advanced imaging technology, AI, and automation. This development aims to improve diagnostic efficiency and image quality. With a GF Score™ of 72/100 and a P/E ratio near its 3-year low, Philips appears stable but faces growth challenges, with no recent insider trading activity.
Oracle Stock Consolidates After Huge Software Rally As Company Ramps Up Multi-Megawatt AI Factories
Oracle Corporation (NYSE: ORCL) stock pulled back after a significant rally in software stocks, with investors taking profits. The company is aggressively expanding its AI data center capacity, delivering 400 megawatts last quarter and anticipating more, to meet high demand. Oracle is set to report earnings on June 10, 2026, with analysts expecting increased EPS and revenue.






